Free Trial
NASDAQ:GRAL

Grail Q1 2025 Earnings Report

Grail logo
$34.50 -1.28 (-3.58%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Grail EPS Results

Actual EPS
N/A
Consensus EPS
-$4.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Grail Revenue Results

Actual Revenue
N/A
Expected Revenue
$35.80 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Grail Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Grail Earnings Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
GRAIL Inc.
See More Grail Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Grail? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grail and other key companies, straight to your email.

About Grail

Grail (NASDAQ:GRAL) is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

View Grail Profile

More Earnings Resources from MarketBeat